This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Japan drug wholesalers Alfresa, Toho and Suzuken to be fined total of $3.6 million for price cartel

By Toko Sekiguchi ( February 7, 2022, 06:26 GMT | Insight) -- Japan’s top pharmaceutical wholesalers Alfresa, Toho Pharmaceutical and Suzuken will be fined 416 million yen ($3.6 million) for rigging bids of prescription drugs sold in 57 hospitals nation-wide through a quasi-public healthcare management operator, MLex has learned. The companies were convicted by the Tokyo District Court last year for the large-scale collusion.Japan’s top pharmaceutical wholesalers Alfresa, Toho Pharmaceutical and Suzuken will be fined 416 million yen ($3.6 million) for rigging bids of prescription drugs sold in 57 hospitals nation-wide through a quasi-public healthcare management operator, MLex has learned....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections